- In October 2024, Oracle announced the general availability of Oracle Health Clinical Data Exchange, a new cloud-based solution designed to streamline medical claims processing through secure, automated data exchange between healthcare providers and payers. Built on Oracle Cloud Infrastructure (OCI), this solution replaces the time-consuming manual transmission of medical records with a secure, centralized network. It aims to reduce administrative time and costs, speed up the approval of essential patient clinical services, and accelerate claims and payment processing.
- In June 2024, Roche announced the launch of its new analytical units, the cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions in countries that accept the CE mark. The cobas pro integrated solutions is a modular and scalable diagnostic platform tailored for high-volume laboratories. The cobas c 703 and cobas ISE neo units feature advanced technology designed to address key challenges faced by diagnostic laboratories globally, such as the shortage of qualified staff and space constraints.
- In June 2024, bioMérieux announced that its VITEK REVEAL AST System, which reports results directly from positive blood cultures, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Rapid and accurate antimicrobial susceptibility testing (AST) results and interpretation are essential for clinicians to quickly optimize therapy and improve patient care. In addition, fast AST supports antimicrobial stewardship (AMS) programs, which have the potential to combat antimicrobial resistance (AMR), a global threat recognized by the WHO.
- In January 2024, QIAGEN announced the launch of two new syndromic testing panels for its QIAstat-Dx instruments in India: the Gastrointestinal Panel 2 and the Meningitis/Encephalitis Panel. These panels join the Respiratory SARS-CoV-2 Panel, which was first authorized for emergency use in 2020. Both new panels have received regulatory approval from the Central Drugs Standard Control Organization (CDSCO), allowing healthcare providers in India to diagnose patients more accurately, quickly, and easily.
- In May 2023, MolGen announced its acquisition of Dutch automation company Synchron Instrumenten BV. This acquisition will enable MolGen to broaden its portfolio and enhance its ability to create advanced automation solutions for DNA/RNA purification, library preparation, and NGS setup, supporting its reagent business. Synchron's expertise in custom liquid handling platforms and rapid prototyping will be leveraged to further expand MolGen's automation offerings.
- In January 2023, BD (Becton, Dickinson and Company) launched a new robotic track system for the BD Kiestra microbiology laboratory solution, designed to automate lab specimen processing and potentially reduce manual labor and wait times for results. The new BD Kiestra 3rd Generation Total Lab Automation System enables laboratories to customize and create flexible automation configurations by connecting multiple BD Kiestra modules. It is also scalable to accommodate the unique and changing needs of different labs.
